Evaluation of the Effectiveness of Staphylococcus Phages in a Skincare Serum against Staphylococcus spp.

IF 3.4 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Cosmetics Pub Date : 2023-11-14 DOI:10.3390/cosmetics10060156
Wattana Pelyuntha, Mingkwan Yingkajorn, Thamonwan Narkpao, Supanida Saeaui, Khemapsorn Promkuljan, Kitiya Vongkamjan
{"title":"Evaluation of the Effectiveness of Staphylococcus Phages in a Skincare Serum against Staphylococcus spp.","authors":"Wattana Pelyuntha, Mingkwan Yingkajorn, Thamonwan Narkpao, Supanida Saeaui, Khemapsorn Promkuljan, Kitiya Vongkamjan","doi":"10.3390/cosmetics10060156","DOIUrl":null,"url":null,"abstract":"The emergence of multidrug-resistant (MDR) Staphylococcus spp. has resulted in the reduced use of antibiotics in many skincare cosmetic products. Alternative treatments using natural bioactive compounds and chemical agents can be replaced. However, these compounds have induced negative side effects among users and are not environmentally friendly. Phage therapy is an alternative to antibiotics for the treatment of specific pathogenic bacteria including Staphylococcus spp., without harmful effects on human skin cells and microflora. Phages can be potentially used in cosmetic products. The direct application of phage-based cosmetic products on skin can reduce the chance of skin infection caused by pathogenic Staphylococcus spp. In the present work, we isolated 17 Staphylococcus phages from sewage and soil samples. Phage A1 showed the highest lytic ability at 50% (B1 profile), covering 13 tested Staphylococcus isolates including Staphylococcus aureus (SA), methicillin-resistant S. aureus (MRSA), S. capitis (SC), and S. epidermidis (SE). Phage A1 reduced the representative S. aureus ATCC 25923 and S. capitis SC1 by 2.0 ± 0.1 and 4.1 ± 0.3 log units at a multiplicity of infection (MOI) of 104 and by 4.2 ± 0.2 and 4.4 ± 0.5 log units at a MOI of 105 after 6 h of post-phage treatment. The transmission electron microscope revealed that phage A1 was classified in the order Caudovirales of the family Myoviridae based on its appearance. Phage A1 showed optimal survival in the presence of a 0.125% (v/v) solidant DMH suspension after 3 h of post-treatment. Under a phage skincare serum formulation, the titers of phage A1 were reduced by 0.46 and 0.85 log units after storage at 4 and 25 °C, whereas a reduction of 2.96 log units was also observed after storage at 37° for 90 days. This study provides strong evidence for the effectiveness of phage application in cosmetic skincare serum for the treatment of skin diseases caused by MDR and pathogenic Staphylococcus spp. The concept of this study could be advantageous for cosmetic and/or cosmeceutical industries searching for new bioactive ingredients for cosmetic/cosmeceutical products.","PeriodicalId":10735,"journal":{"name":"Cosmetics","volume":"66 5","pages":"0"},"PeriodicalIF":3.4000,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cosmetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/cosmetics10060156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The emergence of multidrug-resistant (MDR) Staphylococcus spp. has resulted in the reduced use of antibiotics in many skincare cosmetic products. Alternative treatments using natural bioactive compounds and chemical agents can be replaced. However, these compounds have induced negative side effects among users and are not environmentally friendly. Phage therapy is an alternative to antibiotics for the treatment of specific pathogenic bacteria including Staphylococcus spp., without harmful effects on human skin cells and microflora. Phages can be potentially used in cosmetic products. The direct application of phage-based cosmetic products on skin can reduce the chance of skin infection caused by pathogenic Staphylococcus spp. In the present work, we isolated 17 Staphylococcus phages from sewage and soil samples. Phage A1 showed the highest lytic ability at 50% (B1 profile), covering 13 tested Staphylococcus isolates including Staphylococcus aureus (SA), methicillin-resistant S. aureus (MRSA), S. capitis (SC), and S. epidermidis (SE). Phage A1 reduced the representative S. aureus ATCC 25923 and S. capitis SC1 by 2.0 ± 0.1 and 4.1 ± 0.3 log units at a multiplicity of infection (MOI) of 104 and by 4.2 ± 0.2 and 4.4 ± 0.5 log units at a MOI of 105 after 6 h of post-phage treatment. The transmission electron microscope revealed that phage A1 was classified in the order Caudovirales of the family Myoviridae based on its appearance. Phage A1 showed optimal survival in the presence of a 0.125% (v/v) solidant DMH suspension after 3 h of post-treatment. Under a phage skincare serum formulation, the titers of phage A1 were reduced by 0.46 and 0.85 log units after storage at 4 and 25 °C, whereas a reduction of 2.96 log units was also observed after storage at 37° for 90 days. This study provides strong evidence for the effectiveness of phage application in cosmetic skincare serum for the treatment of skin diseases caused by MDR and pathogenic Staphylococcus spp. The concept of this study could be advantageous for cosmetic and/or cosmeceutical industries searching for new bioactive ingredients for cosmetic/cosmeceutical products.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
护肤精华液中葡萄球菌噬菌体抗葡萄球菌效果的评价。
耐多药葡萄球菌(MDR)的出现导致许多护肤化妆品中抗生素的使用减少。使用天然生物活性化合物和化学制剂的替代疗法是可以替代的。然而,这些化合物对使用者产生了负面的副作用,而且对环境不友好。噬菌体疗法是治疗包括葡萄球菌在内的特定致病菌的一种替代抗生素,对人体皮肤细胞和微生物群没有有害影响。噬菌体可以潜在地用于化妆品。将基于噬菌体的化妆品直接涂抹在皮肤上可以减少致病性葡萄球菌引起皮肤感染的机会。本研究从污水和土壤样品中分离出17种葡萄球菌噬菌体。噬菌体A1的裂解能力最高,达到50% (B1谱),覆盖了13株分离的金黄色葡萄球菌,包括金黄色葡萄球菌(SA)、耐甲氧西林金黄色葡萄球菌(MRSA)、金黄色葡萄球菌(SC)和表皮葡萄球菌(SE)。噬菌体A1对代表性金黄色葡萄球菌ATCC 25923和S. capititis SC1在感染倍数(multiplicity of infection, MOI)为104时减少2.0±0.1和4.1±0.3 log单位,在MOI为105时减少4.2±0.2和4.4±0.5 log单位。透射电镜观察结果显示,噬菌体A1根据外形属于肌病毒科尾状病毒目。在0.125% (v/v)的DMH悬浮液中,噬菌体A1在处理3小时后表现出最佳的存活率。在噬菌体护肤血清制剂下,噬菌体A1的滴度在4℃和25℃保存后分别降低了0.46和0.85个对数单位,在37℃保存90天后也降低了2.96个对数单位。本研究为噬菌体应用于化妆品护肤血清治疗耐多药和致病性葡萄球菌引起的皮肤病提供了强有力的证据,本研究的概念可为化妆品和/或药妆行业寻找化妆品/药妆产品的新生物活性成分提供有利的依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cosmetics
Cosmetics Medicine-Surgery
CiteScore
5.20
自引率
12.10%
发文量
108
审稿时长
8 weeks
期刊最新文献
Microtopography and Barrier Function in Healthy Skin: Differences between Forearm, Cheek and Palm An Assessment of the Effectiveness and Safety of ULTRACOL100 as a Device for Restoring Skin in the Nasolabial Fold Region Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis The Potential of Grapevine Leaf Extract in Treating Hyperpigmentation Meta-Analysis and Analytical Methods in Cosmetics Formulation: A Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1